Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis

Published:2022-11-29 Issue:1 Volume:4 Page:291-293
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Tseng Chen I.¹^ORCID,Roddick Alistair J.¹,Bottomley Matthew J.¹²,Shapiro Susan³⁴⁵^ORCID,Udayaraj Udaya¹²

Affiliation:

1. Oxford Kidney Unit, Churchill Hospital Oxford University Hospitals NHS Foundation Trust Oxford UK

2. Nuffield Department of Medicine University of Oxford Oxford UK

3. Oxford Haemophilia and Thrombosis Centre, Churchill Hospital Oxford University Hospitals NHS Foundation Trust Oxford UK

4. Radcliffe Department of Medicine University of Oxford Oxford UK

5. Oxford NIHR Biomedical Research Centre Oxford UK

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.606

Reference10 articles.

1. Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis

2. Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease

3. Calciphylaxis

4. Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries

5. Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin in Patients With Chronic Kidney Disease and Atrial Fibrillation

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and factors associated with inappropriate dosing of apixaban and rivaroxaban in hospitalized older adults with atrial fibrillation: a cross-sectional study;Drugs & Aging;2023-11-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3